Multi-modal Adverse Events Prediction for Premature Coronary Heart Disease Trial: MAP-CHD Trial
Condition(s) studied
Study summary
The goal of this observational cohort study is to establish a risk prediction model for adverse events in Chinese individuals under 45 years old with premature coronary artery disease. The main questions it aims to answer are:
* What are the major risk factors for poor prognosis in Chinese patients with premature coronary artery disease?
* What is the difference in the prognosis of patients with premature coronary heart disease with different phenotypes? Participants taking no mandatory intervention will be followed up for 2 year, with blood tests at 1 year and outpatient or telephone interviews at other timepoints.
Eligibility
Primary outcome measure(s)
- MACCE, defined as a composite of cardiac death, MI, ischemic stroke, and repeat revascularization — 2 years
- Sensitivity for 2-year MACCE prediction — 2 years
For the validation cohort - Specificity for 2-year MACCE prediction — 2 years
For the validation cohort
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| FuWai Hospital | Beijing | China | Recruiting |
More China National Center for Cardiovascular Diseases trials in China
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07004452 on ClinicalTrials.gov ↗ ← All trials in China